|
1.
|
Chen F and Huang K: Effects of the Chinese
medicine matrine on experimental C. parvum infection in
BALB/c mice and MDBK cells. Parasitol Res. 111:1827–1832. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Wan XY, Luo M, Li XD and He P:
Hepatoprotective and anti-hepatocarcinogenic effects of
glycyrrhizin and matrine. Chem Biol Interact. 181:15–19. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Jong TT, Lee MR, Chiang YC and Chiang ST:
Using LC/MS/MS to determine matrine, oxymatrine, ferulic acid,
mangiferin, and glycyrrhizin in the Chinese medicinal preparations
Shiau-feng-saan and Dang-guei-nian-tong-tang. J Pharm Biomed Anal.
40:472–477. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Yin LL and Zhu XZ: The involvement of
central cholinergic system in (+)-matrine-induced antinociception
in mice. Pharmacol Biochem Behav. 80:419–425. 2005.
|
|
5.
|
Kobashi S, Takizawa M, Kubo H, Yamauchi T
and Higashiyama K: Antinociceptive effects of
N-acyloctahydropyrido[3,2,1-ij] [1,6]naphthyridine in mice:
structure-activity relation study of matrine-type alkaloids part
II. Biol Pharm Bull. 26:375–379. 2003.PubMed/NCBI
|
|
6.
|
Yang Y, Xiu J, Zhang X, Zhang L, Yan K,
Qin C and Liu J: Antiviral effect of matrine against human
enterovirus 71. Molecules. 17:10370–10376. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Zhang S, Zhang Y, Zhuang Y, et al: Matrine
induces apoptosis in human acute myeloid leukemia cells via the
mitochondrial pathway and akt inactivation. PLoS One. 7:e468532012.
View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Fu S, Sun C, Tao X and Ren Y:
Anti-inflammatory effects of active constituents extracted from
Chinese medicinal herbs against Propionibacterium acnes. Nat
Prod Res. 26:1746–1749. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Zhao X, Kan Q, Zhu L and Zhang GX: Matrine
suppresses production of IL-23/IL-17 and ameliorates experimental
auto-immune encephalomyelitis. Am J Chin Med. 39:933–941. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Xu M, Yang L, Hong LZ, Zhao XY and Zhang
HL: Direct protection of neurons and astrocytes by matrine via
inhibition of the NF-κB signaling pathway contributes to
neuroprotection against focal cerebral ischemia. Brain Res.
1454:48–64. 2012.PubMed/NCBI
|
|
11.
|
Zhang J, Li Y, Chen X, et al: Autophagy is
involved in anticancer effects of matrine on SGC-7901 human gastric
cancer cells. Oncol Rep. 26:115–124. 2011.PubMed/NCBI
|
|
12.
|
Liu XY, Ruan LM, Mao WW, Wang JQ, Shen YQ
and Sui MH: Preparation of RGD-modified long circulating liposome
loading matrine, and its in vitro anti-cancer effects. Int J Med
Sci. 7:197–208. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Yu P, Liu Q, Liu K, Yagasaki K, Wu E and
Zhang G: Matrine suppresses breast cancer cell proliferation and
invasion via VEGF-Akt-NF-kappaB signaling. Cytotechnology.
59:219–229. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Kelliher MA, Grimm S, Ishida Y, Kuo F,
Stanger BZ and Leder P: The death domain kinase RIP mediates the
TNF-induced NF-κB signal. Immunity. 8:297–303. 1998.
|
|
15.
|
Ting AT, Pimentel-Muiños FX and Seed B:
RIP mediates tumor necrosis factor receptor 1 activation of NF-κB
but not Fas/APO-1-initiated apoptosis. EMBO J. 15:6189–6196.
1996.
|
|
16.
|
Zhang J and Winoto A: A mouse
Fas-associated protein with homology to the human Mort1/FADD
protein is essential for Fas-induced apoptosis. Mol Cell Biol.
16:2756–2763. 1996.PubMed/NCBI
|
|
17.
|
Karin M, Yamamoto Y and Wang QM: The IKK
NF-κB system: a treasure trove for drug development. Nat Rev Drug
Discov. 3:17–26. 2004.
|
|
18.
|
Yang J, Lin Y, Guo Z, et al: The essential
role of MEKK3 in TNF-induced NFκB activation. Nat Immunol.
2:620–624. 2001.PubMed/NCBI
|
|
19.
|
Wu MX, Ao Z, Prasad KV, Wu R and
Schlossman SF: IEX-1L, an apoptosis inhibitor involved in
NF-κB-mediated cell survival. Science. 281:998–1001. 1998.
|
|
20.
|
Wang CY, Mayo MW, Korneluk RG, Goeddel DV
and Baldwin AS Jr: NFκB antiapoptosis: induction of TRAF1 and TRAF2
and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science.
281:1680–1683. 1998.
|
|
21.
|
Kamata H, Honda S, Maeda S, Chang L,
Hirata H and Karin M: Reactive oxygen species promote
TNFalpha-induced death and sustained JNK activation by inhibiting
MAP kinase phosphatases. Cell. 120:649–661. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Broemer M, Krappmann D and Scheidereit C:
Requirement of Hsp90 activity for IkappaB kinase (IKK) biosynthesis
and for constitutive and inducible IKK and NF-kappaB activation.
Oncogene. 23:5378–5386. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Lewis J, Devin A, Miller A, et al:
Disruption of hsp90 function results in degradation of the death
domain kinase, receptor-interacting protein (RIP), and blockage of
tumor necrosis factor-induced nuclear factor-kappaB activation. J
Biol Chem. 275:10519–10526. 2000. View Article : Google Scholar
|
|
24.
|
Park DH, De Xu H, Shim J, et al:
Stephania delavayi Diels inhibits breast carcinoma
proliferation through the p38 MAPK/NF-κB/COX-2 pathway. Oncol Rep.
26:833–841. 2011.
|
